Alyeska Investment Group’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$151K	Hold	100,000	–	–	﹤0.01%	538
2025 Q1	$300K	Hold	100,000	–	–	﹤0.01%	479
2024 Q4	$1.01M	Hold	100,000	–	–	﹤0.01%	495
2024 Q3	$1.55M	Buy	+100,000	New	+$1.55M	0.01%	437